Emanuela Grassilli, Ph.D.Università degli Studi di Milano-Bicocca (University of Milano – Bicocca)Monza, Italy Project: p65BTK as an actionable target in ovarian cancer Research Area: Novel Therapy Summary:Dr. Grassilli proposes to test treatment of ovarian cancer with drugs that target a protein called p65BTK which is expressed by ovarian cancer cells. She recently identified p65BTK as a protein […]
Read MoreStarting April 1, 2025, the Rivkin Center’s ovarian cancer research funding, global symposium and fundraising activities will continue under the leadership of Ovarian Cancer Research Alliance (OCRA).